Axitinib in first-line for patients with metastatic papillary renal cell carcinoma: Results of the multicentre, open-label, single-arm, phase II AXIPAP trial

Sylvie Négrier, Nathalie Rioux-Leclercq, Céline Ferlay, Marine Gross‐Goupil, Gwénaëlle Gravis, L. Geoffrois, Christine Chevreau, Helen Boyle, Frédéric Rolland, Ellen Blanc, Alain Ravaud, Slimane Dermeche, Aude Fléchon, Laurence Albigès, David Pérol, Bernard Escudier